BioSpace News Archive

Vaginal Specula Market is Expected To Reach USD 1,106.5 Million By 2028 at a CAGR of 3.2%

Growing prevalence of cervical cancer is one of the significant factors influencing market growth.

September 14, 2022
·
6 min read
Transcranial Magnetic Stimulators Market is Expected To Reach USD 1.82 Billion By 2027 at a CAGR of 8.3%

The increase in the prevalence of Parkinson’s and Alzheimer’s diseases and rising awareness regarding the transcranial magnetic stimulators are driving the market.

September 14, 2022
·
7 min read
Hemodynamic Monitoring Market Size to Reach Valuation of USD 1,566.7 Million in 2028

Hemodynamic monitoring is the process of measuring various blood flow parameters.

September 14, 2022
·
6 min read
Drug Development

AB Science - Positive recommendation of the Data and Safety Monitoring Board to continue the Phase 2 study evaluating the antiviral activity of masitinib in Covid-19

AB Science SA (Euronext - FR0010557264 - AB) today announced continuation of the Phase 2 study evaluating the antiviral activity of masitinib in patients who have a confirmed diagnosis of COVID-19, following the recommendation of the Data and Safety Monitoring Board (DSMB).

September 14, 2022
·
3 min read
Deals

Harris Williams Advises PharmaLex Group on its Pending Sale to AmerisourceBergen

Harris Williams, a global investment bank specializing in M&A advisory services, announces it is advising PharmaLex Group (PharmaLex) on its pending sale to AmerisourceBergen.

September 14, 2022
·
4 min read
Business

Nurix Therapeutics Appoints Leading Industry Strategist Edward C. Saltzman to its Board of Directors

Nurix Therapeutics, Inc. today announced the appointment of Edward C. Saltzman to its board of directors.

September 14, 2022
·
4 min read
Drug Development

Eloxx Pharmaceuticals Reports Topline Results from Phase 2 Combination Clinical Trial of ELX-02 in Class 1 Cystic Fibrosis (CF) Patients

Eloxx Pharmaceuticals, Inc. (NASDAQ: ELOX), a leader in ribosomal RNA-targeted genetic therapies for rare diseases, today announced topline results from the Phase 2 clinical trial of ELX-02 in combination with ivacaftor in Class 1 cystic fibrosis (CF) patients with at least one nonsense mutation.

September 14, 2022
·
7 min read
Lone Star Bio

Savara Announces New Employment Inducement Grant Under NASDAQ Listing Rule 5635(c)(4) - September 14, 2022

Savara Inc., a clinical stage biopharmaceutical company focused on rare respiratory diseases, announced the grant of inducement awards to three new employees.

September 14, 2022
·
1 min read
Business

QIAGEN and Neuron23 Partner to Develop Next-Generation Sequencing Companion Diagnostic for Novel Parkinson’s Disease Drug

QIAGEN (NYSE:QGEN; Frankfurt Prime Standard: QIA) and Neuron23 Inc. today announced the signing of an agreement to develop a companion diagnostic for Neuron23’s brain penetrant leucine-rich repeat kinase (LRRK2) inhibitor for Parkinson’s disease.

September 14, 2022
·
7 min read
Biotech Bay

Bristol Myers Squibb Announces Dividend - September 14, 2022

Bristol Myers Squibb announced that its Board of Directors has declared a quarterly dividend of fifty-four cents per share on the $.10 par value common stock of the company.

September 14, 2022
·
1 min read